Postoperative Adjuvant Chemotherapy with CDDP+VDS for Non-small Cell Lung Cancer-A Randomized, Controlled Trial.
スポンサーリンク
概要
- 論文の詳細を見る
A randomized, controlled trial was performed to determine whether postoperative adjuvant chemotherapy with CDDP+VDS can improve the survival rate in patients with non-small cell lung cancer (NSCLC) undergoing curative or relatively non curative resection. Stage I patients were divided in Group A (CDDP+VDS and 2 years of 5-FU p. o.) and Group B (no treatment). Stage II, III patients were divided in Group C (2 courses of CDDP+VDS and 2 years of 5-FU p. o.) and Group D (2 years of 5-FU p. o. only). The numbers of patients in Groups A, B, C and D were 63, 66, 32 and 31 respectively. Postoperative 5-year-survival rates were 79.4% for Group A, 86.3% for Group B, 25.0% for Group C and 22.6% for Group D. Thus postoperative adjuvant chemotherapy with CDDP+VDS did not improve the 5-year survival rate.
- 特定非営利活動法人 日本肺癌学会の論文
特定非営利活動法人 日本肺癌学会 | 論文
- 診療科からみた新しいTNM病期分類（UICC-7）の問題点と課題?画像診断からみた問題点と課題?
- 新潟県における肺がんの解析
- 慢性血栓塞栓性肺高血圧症合併肺腺癌に対する左上葉切除術を施行した1例
- 肺がん検診における判定基準の改訂（2）：B，C，D判定に関して
- 片側性多発脳神経障害（Garcin症候群）を契機に発見され，化学療法により神経症状の改善を得た小細胞肺癌の1例